SEC Tracker
Get the app

Acceleron Pharma

Acceleron Pharma: quarterly report for the quarter ended Sep 30, 2017

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.2
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Acceleron Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX

Data on this page was fetched . The filing on SEC.gov is the record.